News
October 13, 2011
Zafgen Appoints Business Development Veteran Frances K. Heller to Board of Directors
September 28, 2011
Zafgen to Present at The Obesity Society 29th Annual Scientific Meeting
September 21, 2011
Zafgen Appoints Industry Executive Dennis Kim, M.D., M.B.A., to Chief Medical Officer
July 7, 2011
Zafgen Secures $33 Million Series C Financing
June 24, 2011
Zafgen Announces Cardiovascular Data from Phase 1b Study of ZGN-433 in Obesity at American Diabetes Association Annual Meeting
May 16, 2011
Dalton and Zafgen Enter Into Aseptic Fill Services Agreement
April 8, 2011
Zafgen to Present at BioCentury Future Leaders in the Biotech Industry Conference
January 5, 2011
Zafgen Announces Positive Topline Phase 1b Data for ZGN-433 in Obesity
June 26, 2010
Zafgen Presents Data on a New Class of Medicines to Treat Obesity at the American
Diabetes Association Annual Meeting 
October 26, 2009
Zafgen, Inc. to Present at Upcoming Conferences
Zafgen, Inc. Announces Participation at XSITE 2009
May 14, 2009
Zafgen, Inc. Announces Participation at BIO 2009 International Convention
May 5, 2009
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development
April 27, 2009
Zafgen, Inc. to Present at Xconomy Forum
March 25, 2009
Zafgen, Inc. to Present at Upcoming Conferences
January 29, 2009
Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity
October 16, 2008
Zafgen Inc. to Present at First Annual Boston Biotech R&D Conference
September 9, 2008
Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company’s First Chief Executive Officer
